Laguna Acquires the Exclusive CannaCeuticals CBD Skin Care Licenses

KELOWNA, BC – October 31, 2016 – Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A), today announces the exclusive Cannaceutical CBD skin care license has been expanded into Japan, Germany, Thailand and South Korea.
ISO International LLC (“ISO”), (the supplier for Cannaceuticals) has granted to Laguna the exclusive, transferable, perpetual, irrevocable, royalty-free right and license to distribute the products in the licensed territories, either under the product trademarks or on a white label basis. In addition, Laguna may sub-license these rights and licenses to any third party without the consent of the supplier.
The expansion of the additional licensed territories in Asia and Europe fast tracks Laguna to be a worldwide player in the distribution of Cannabidiol (“CBD”) skin care products. The global skin care industry is currently estimated at $121 billion US and the market demand for CBD products is growing at an expediential rate.
Laguna is positioning itself in the multibillion dollar skin care market. Laguna’s market strategy is online sales, joint ventures and through licensing opportunities.
Laguna previously announced that it had received an exclusive license for the CannaCeutical product line in the USA and Canada, see press release dated August 09, 2016. Laguna launched sales of the Cannaceutical products in the USA on September 13th of 2016.
Stuart Gray, CEO of Laguna Blends said, “By acquiring the additional exclusive licenses in Japan, Germany, Thailand and South Korea we can capitalize on the global demand for high quality skin care products.” Stuart Gray went on to say, “We feel there is nothing like the Cannaceutical product line anywhere in the world today and in a recent clinical study evaluating the efficacy of Canna’s CBD facial serum, test subjects using the product noted a 100% overall improvement to the appearance of skin in just two weeks.”
Connect with Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) to receive an Investor Presentation.